Please login to the form below

Not currently logged in
Email:
Password:

NHS Commissioning Board Authority launches

Board Authority will focus on designing an innovative business model for the Board subject to the passage of the Health and Social Care Bill 2011

The UK's Department of Health has announced the launch of the NHS Commissioning Board Authority.

The Authority will focus on designing a business model for the Board subject to the passage of the Health and Social Care Bill 2011.

It will work in partnership with clinical commissioning group leaders, GPs and the Department of Health to agree the method for establishing, authorising and running clinical commissioning groups (CCGs), with patients and clinical leadership at the centre.

The central role of the new Board will be to improve patient outcomes, by supporting, developing and performance managing an effective system of clinical commissioning groups who are set to be in charge of the £80bn commissioning budget.

The Board will also take responsibility for some commissioning services at a national or a regional level.

Sir David Nicholson, NHS Chief Executive said: "Building this new system over the next two years, while delivering for our patients, increasing productivity and improving the quality of care, is a major challenge. But I firmly believe that what we are trying to achieve – a stronger, more innovative and more coherent commissioning system – will be critical to sustaining the NHS in years to come."

Subject to successful passage of the Health and Social Care Bill 2011 through Parliament, it is anticipated the NHS Commissioning Board will become fully operational on April 1, 2013, when it takes on its complete legal responsibilities for managing the NHS Commissioning system.

31st October 2011

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics